Keywords: liposome, co, completes, ph, ii, tlc, c-53

Liposome Co Completes Ph II TLC C-53 ARDS Trials

Article | 30 January 1995

Print This

Phase I/II clinical trials of TLC C-53 (liposomal prostaglandin E1) as a treatment for acute respiratory distress syndrome have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in